Intimation of Schedule of Meeting with Analyst/Institutional Investor on August 13, 2026 and August 14, 2026.

Ref: Syn/CS/SE/Reg 30/2026-27/Aug/02 Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India T +91 80 6891 9191 CIN: L85110KA1993PLC014937 August 10, 2026 www.syngeneintl.com To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Corporate Communication Department Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051 Scrip Code: 539268 Scrip Symbol: SYNGENE Dear Sir/Ma’am, Subject: Intimation of Schedule of Meeting with Analyst/Institutional Investor Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the details of the meeting to be held with the Analyst/Institutional Investor. Sl. Date Name of the Type of Nature of Venue No. Analyst/Investor meeting meeting 1. August 13, 2026 Emkay Confluence In Person Group / One- Mumbai and August 14, 2026 conference on-one 2026 organized by Emkay Meeting Global It is hereby notified that the Company shall not be disclosing any Unpublished Price Sensitive Information (UPSI) during the upcoming analyst/investor meeting. The above-mentioned information will also be made available on the website of the Company www.syngeneintl.com. Request to kindly take this intimation on record. Thanking You, Yours faithfully, For SYNGENE INTERNATIONAL LIMITED Chethan Yogesh Company Secretary & Compliance Officer